Skip to content
April 25, 2024

Equity.Guru

Investment information for the new generation

Search

Chief Medical Officer

Core One Labs (COOL.C) announced their wholly-owned subsidiary, Akome Biotech, has begun the development of its patent-pending psychedelic drug formulation for the treatment of Alzheimer’s Disease. Akome’s “next-generation” psychedelic…